Literature DB >> 11565831

Dendritic cell-dead cell interactions: implications and relevance for immunotherapy.

J F Fonteneau1, M Larsson, N Bhardwaj.   

Abstract

Dendritic cells are a system of antigen-presenting cells with an essential role in the initiation and development of immune responses against infections or tumors. Their unique capacity to stimulate T cells is being adapted for use in immunotherapy. In this review, we focus on their ability to interact with dead cells and, notably, to present exogenous antigens acquired from them to CD8+ T cells. We also discuss the role of this unique antigen presentation pathway for immunotherapeutic development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565831     DOI: 10.1097/00002371-200107000-00005

Source DB:  PubMed          Journal:  J Immunother        ISSN: 1524-9557            Impact factor:   4.456


  3 in total

1.  Low-dose chemotherapeutic agents regulate small Rho GTPase activity in dendritic cells.

Authors:  Galina V Shurin; Irina L Tourkova; Michael R Shurin
Journal:  J Immunother       Date:  2008-06       Impact factor: 4.456

2.  Biased epitope selection by recombinant vaccinia-virus (rVV)-infected mature or immature dendritic cells.

Authors:  D Nagorsen; M Panelli; M E Dudley; S E Finkelstein; S A Rosenberg; F M Marincola
Journal:  Gene Ther       Date:  2003-09       Impact factor: 5.250

Review 3.  Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules.

Authors:  Ashley M Cimino; Purani Palaniswami; Andrew C Kim; Periasamy Selvaraj
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.